CHANDLER, Ariz. (AP) _ Insys Therapeutics Inc. (INSY) on Wednesday reported a loss of $27.4 million in its second quarter.

The Chandler, Arizona-based company said it had a loss of 37 cents per share. Losses, adjusted for stock option expense, were 33 cents per share.

The specialty pharmaceutical company posted revenue of $23.5 million in the period, which did not meet Street forecasts. Three analysts surveyed by Zacks expected $25.4 million.

Insys Therapeutics shares have declined 19 percent since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $7.79, a drop of 16 percent in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on INSY at https://www.zacks.com/ap/INSY